search
Back to results

Planned Semi-Elective Lung Transplantation Using 10C Cold Static Preservation

Primary Purpose

Pulmonary Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Delayed Lung Transplantation
Conventional Lung Transplantation
Sponsored by
NYU Langone Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pulmonary Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Recipient is ≥ 18 years old
  • Recipient, or their Legally Authorized Representative is able and willing to sign informed consent
  • Recipient meets standard listing criteria for lung transplantation

Exclusion Criteria:

  • Donor lungs meet criteria for transplantation with ex vivo lung perfusion (EVLP)
  • Recipient is < 18 years old
  • Recipient, or their Legally Authorized Representative is unable to sign informed consent for re-transplantation
  • Recipient has any condition that, in the opinion of the Investigator, would make study participation unsafe or would interfere with the objectives of the study

Sites / Locations

  • NYU Langone Health

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Delayed Lung Transplantation

Conventional Lung Transplantation

Arm Description

Patients that received lung(s) delayed for transplantation

Reference Therapy

Outcomes

Primary Outcome Measures

Incidence of ISHLT primary graft dysfunction grade 3 at 72 hours post-transplant
As defined by International Society of Heart and Lung Transplantation (ISHLT)

Secondary Outcome Measures

Full Information

First Posted
September 25, 2020
Last Updated
July 20, 2022
Sponsor
NYU Langone Health
search

1. Study Identification

Unique Protocol Identification Number
NCT04568694
Brief Title
Planned Semi-Elective Lung Transplantation Using 10C Cold Static Preservation
Official Title
Planned Semi-Elective Lung Transplantation Using 10C Cold Static Preservation: A Proof-of-Concept Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
November 30, 2020 (Actual)
Primary Completion Date
December 3, 2021 (Actual)
Study Completion Date
December 3, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NYU Langone Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a prospective, single-arm study to demonstrate the proof-of-concept of semi-elective lung transplantation. We plan to evaluate 15 patients that receive lung(s) delayed for transplantation under our study criteria.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
1 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Delayed Lung Transplantation
Arm Type
Experimental
Arm Description
Patients that received lung(s) delayed for transplantation
Arm Title
Conventional Lung Transplantation
Arm Type
Active Comparator
Arm Description
Reference Therapy
Intervention Type
Procedure
Intervention Name(s)
Delayed Lung Transplantation
Intervention Description
Transplants with a planned recipient anesthesia start time between 10:00 pm and 6:00 am will be allowed to move to a start time between 6:00 am and 8:00 am at the earliest. Donor lung(s) cross clamp time must occur between 5:00 pm and 4:00 am. Lungs that meet criteria will be transported in the usual fashion in a cooler of ice at 4oC. Upon arrival to NYULH, the lungs will be transferred to cold static preservation at 10oC within a specific incubator located in a NYULH OR (MYTEMP™65HC, Benchmark Scientific).
Intervention Type
Procedure
Intervention Name(s)
Conventional Lung Transplantation
Intervention Description
Reference Therapy
Primary Outcome Measure Information:
Title
Incidence of ISHLT primary graft dysfunction grade 3 at 72 hours post-transplant
Description
As defined by International Society of Heart and Lung Transplantation (ISHLT)
Time Frame
72 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Recipient is ≥ 18 years old Recipient, or their Legally Authorized Representative is able and willing to sign informed consent Recipient meets standard listing criteria for lung transplantation Exclusion Criteria: Donor lungs meet criteria for transplantation with ex vivo lung perfusion (EVLP) Recipient is < 18 years old Recipient, or their Legally Authorized Representative is unable to sign informed consent for re-transplantation Recipient has any condition that, in the opinion of the Investigator, would make study participation unsafe or would interfere with the objectives of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nader Moazami, MD
Organizational Affiliation
NYU Langone Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
NYU Langone Health
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to the PI. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.
IPD Sharing Time Frame
Beginning 9 months and ending 36 months following article publication
IPD Sharing Access Criteria
Requests may be directed to the PI.

Learn more about this trial

Planned Semi-Elective Lung Transplantation Using 10C Cold Static Preservation

We'll reach out to this number within 24 hrs